Oprelvekin
Product Approval Information - Licensing Action
Proper name: Oprelvekin
Tradename: Neumega
Manufacturer: Genetics Institute, Inc, St. Davids, PA, License #1163
Revised Package Insert: To state that a safe and effective dose has not been established for pediatric patients and to add important new safety information
Approval Date: 9/18/2002
Type of submission: Biologics license application supplement
Approval Letter -
(PDF)
Label
(PDF)
Last Updated: 3/21/2003
Back
to Top
Back to Index
Updated: September 25, 2003 |